搜索结果: 1-6 共查到“感染性疾病学 Treatment”相关记录6条 . 查询时间(0.109 秒)
Treatment Following Intoxication With Lethal Dose of Paraquat: A Case Report and Review of Literature
Paraquat Antioxidants Acetylcysteine Vitamin E
font style='font-size:12px;'>
2015/11/9
Introduction: Paraquat is a widely used nitrogen-based herbicide which is lethal and causes multi-organ failure by accumulation in cells, which subsequently leads to death.
Treatment of viral hepatitis in China: better clinical research and improved practice
viral hepatitis therapeutics China advance
font style='font-size:12px;'>
2011/4/2
Hepatitis virus infection, especially chronic infection
with hepatitis B virus (HBV) and hepatitis C virus
(HCV), is a serious issue to global public health.
Although the prevalence of HBsAg in the...
Virological, serological and biochemical outcomes through 3 years of entecavir treatment in nucleoside-naive Chinese chronic hepatitis B patients
Virological biochemical entecavir treatment
font style='font-size:12px;'>
2011/4/2
Hepatitis B virus (HBV) infection has a high prevalence
in China. Entecavir has shown superior efficacy over
lamivudine in Chinese nucleoside-naive chronic hepatitis B
(CHB) patients over 48 weeks,...
Monotherapy versus combination therapy for the treatment of chronic hepatitis B
Monotherapy versus therapy the treatment of chronic hepatitis B
font style='font-size:12px;'>
2011/4/2
Nucleos(t)ide analogues, active against hepatitis B polymerase, suppress viral replication and improve clinical outcome. However, the emergence of drug-resistant mutants can result in treatment failur...
Treatment for hepatitis B
Hepatitis B virus Treatment
font style='font-size:12px;'>
2011/4/2
Hepatitis B virus is estimated to have infected 350 million individuals globally, accounting for over 500 000 deaths each year.1 An effective and widely available vaccine provides protection from infe...
HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B
HBeAg seroconversion in the treatment of chronic hepatitis B
font style='font-size:12px;'>
2011/4/1
During the natural history of chronic hepatitis
B virus (HBV) infection, the loss of serum hepatitis B e
antigen (HBeAg) and the development of anti-HBe antibodies
(HBeAg seroconversion) mark a tra...